Mylan said U.S. health regulators were unable to approve its generic version of GlaxoSmithKline's blockbuster inhaled lung drug Advair for the second time.


00


CNBC

Latest News

CNBC: Top plays if it turns into a cruel summer for stocks

CNBC: Gold hits a 2018 low and one trader is betting on an even bigger drop

CNBC: Trader bets against today's bitcoin bounce

CNBC: Traders bet one soaring tech stock is about to lose steam

NBC New York: Springsteen “Born to Run” Lyrics Expected to Fetch $300K

CTV News: Doug Ford says hiring freeze won't include teachers, nurses

CTV News: Blue-green algae bloom advisory issued for Isle Lake

Reuters: Senate backers of ZTE measure ready to battle Trump over Chinese firm

Reuters: Verizon to stop selling phone location data to third parties

Reuters: GRAPHIC-From the Aussie to soybeans and cars: what's at risk in a trade war?

Reuters: Ferragamo family holding to sell 3.5 percent in Italian luxury group

Reuters: UPDATE 1-Verizon to stop selling phone location data to third parties

Reuters: RPT-GRAPHIC-From the Aussie to soybeans and cars: what's at risk in a trade war?

Reuters: Verizon to stop selling phone location data to third parties

Times of Israel: Jewish extremists taunt ‘Ali’s on the grill’ at slain toddler’s relatives

WashingtonPost: Health care is about to get way easier for small businesses and self-employed Americans

WashingtonPost: Cheesy French toast is a mashup we can all get behind

WashingtonPost: Roche Does Pharma M&A Without the Pharma

NewYorkTimes: As U.S. Divides Migrant Families, It Bids Americans Bon Voyage

FOX: McDonald's new coffee 'better than anything Starbucks has ever come up with,' according to Twitter

FOX: Banned ex-FIFA president Blatter in Russia for World Cup

FOX: Alligator taken, dumped at Florida Wawa; two suspects sought, police say

FOX: Banned ex-FIFA president Blatter in Russia for World Cup

14 Related Articles from 2018-06-13